Bcel stock forecast.
Analyst projections state that BCEL is forecast to be at a low of $1.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -3361.54% from its current level, while the stock would need to crash -284.62% from its current level to reach the projected low. Atreca Inc (BCEL) estimates and forecasts
If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks.Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now Zacks - Thu Apr 6, 8:55AM CDT . Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall... HOOK Stock 12 Months Forecast. $6.83. (1382.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Hookipa Pharma in the last 3 months. The average price target is $6.83 with a high forecast of $7.00 and a low forecast of $6.50. The average price target represents a 1382.20% change from the last price of $0.46.
Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...
Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response.
BCEL BCEL Atreca Inc - Ordinary Shares - Class A 2,464 Watch Alerts $0.223 $0.0092 (4.30%) Today $0.23 0.0035 (1.57%) After Hours About Feed News Sentiment Earnings …Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 28, 2023 · A high-level overview of Atreca, Inc. (BCEL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Track Atreca Inc - Ordinary Shares - Class A (BCEL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...
Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.
Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The ...Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company’s product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-002 and VRDN ...About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).12 brokerages have issued 1-year price targets for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they expect the company's stock price to reach $22.27 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price. View analysts price targets for …Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25. Nov 30, 2023 · Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | Nasdaq
The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ... 9.19M. AMZN. 146.74. +0.02%. 21.10M. New. View today's Atreca Inc stock price and latest BCEL news and analysis. Create real-time notifications to follow any changes in the live stock price.Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,509.52%. …Aug 14, 2023 · BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share). Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...
The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for …
Price target. 1.93D CAD +1.58 +451.02%. The 7 analysts offering 1 year price forecasts for ENTHUSIAST GAMING HOLDINGS INC have a max estimate of 2.50 and a min estimate of 1.50. Find real-time CBAY - CymaBay Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for …Nov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum. Complete Atreca Inc. Cl A stock information by Barron's. View real-time BCEL stock price and news, along with industry-best analysis.BCEL vs Biotech Stocks. Ticker Inst. % Insider % Net Insider (L12M) Net Insider (L3M) BCEL: 31.32%: 21.52%: Net Selling: Net Selling: IMNN: 4.39%: 92.03%: FRES: 0.00%: 0.00%: ... Top Performing Analysts Stock Screener Stock Forecast Trending Stocks Strong Buy Stocks Highest Earnings Stocks Best Dividend Paying Stocks Statistics …According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.ATRECA, INC. stock price forecast for further price development down to -100.00% (time horizon: 1 day) and price target of 0.00 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) ATRECA, INC. share price prediction for 2024-01-12 with daily closed price projectionsAtreca (BCEL) suspends the development of only pipeline candidate, ATRC-101, in clinical evaluation, as part of its business restructuring efforts and cuts headcount by 40%. The stock falls 37%.
Atreca, Inc. - Hold. Zacks' proprietary data indicates that Atreca, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the BCEL shares relative to the market in ...
12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...
$191.45 +1.76 +0.93% Find the latest analyst research for Atreca, Inc. Class A Common Stock (BCEL) at Nasdaq.com.Based on short-term price targets offered by four analysts, the average price target for Atreca, Inc. comes to $5.25. The forecasts range from a low of $1.00 to a high of $10.00. The average price ...May 6, 2023 · Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00. Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Allakos Inc have a median target of 9.50, with a high estimate of 22.00 and a low estimate of 1.50. The median estimate ... Atreca Inc - Class A Stock Chart and Share Price Forecast, Short-Term "BCEL" Stock Prediction for Next Days and Weeks Walletinvestor.com Atreca Inc - Class A (BCEL) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Atreca Inc [BCEL] stock prices are down -14.82% to $0.28 at the moment. ... An investor can expect a potential return of 1060.71% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In this publicly-traded organization, revenue per employee is $8,556, ...Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ... VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.Find the latest Patterson-UTI Energy, Inc. (PTEN) stock quote, history, news and other vital information to help you with your stock trading and investing.May 6, 2023 · Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00. $0.22 USD +0.01 (2.90%) Updated Nov 27, 2023 11:22 AM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value | A Growth | C Momentum | C VGM Industry …Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now Zacks - Thu Apr 6, 8:55AM CDT . Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...
Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below. According to present data Coterra Energy's CTRA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Instagram:https://instagram. solar edge stocktop 10 stocks to buy nowwebull or etradecre stock Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ... Last reporting date. November 13, 2023. EPS forecast (this quarter) -$68.00. Annual revenue (last year) $1.1B. Annual profit (last year) -$415.6M. Net profit margin. mmm price targetannuity best rate Nov 27, 2023 · Analyst Forecast. According to 5 analysts, the average rating for BCEL stock is "Hold." The 12-month stock price forecast is $3.38, which is an increase of 1,479.44% from the latest price. most fun cities in the us Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ...Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business. Aug 7, 2023 · BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the Aug. 7, 2023 when the stock price was at 0.91$. In the short term (2weeks), BCEL's stock price should underperform the market by -3.07%. During that period the price should oscillate between -9.61% and +7.63%.